Results 171 to 180 of about 2,075 (191)

Anaphylaxis to Botulinum Antitoxin: A Systematic Review

Journal of Allergy and Clinical Immunology, 2017
Edith Schussler, Joy Hsu, Patricia Yu, Leslie C. Grammer, Anna H. Nowak-Wegrzyn   +4 more
openaire   +1 more source

Source of Botulinum Antitoxin Products Needs Clarifying

Pediatric Annals, 2010
LCDR Ryan P. Fagan, CAPT Hye-Joo Kim
openaire   +1 more source

Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019

Toxins, 2023
Carmen Varela, Sylvia Valdezate, Gema Carrasco   +2 more
exaly  

A Novel Running Wheel Mouse Model for Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy

Antimicrobial Agents and Chemotherapy, 2021
Ran Zichel, Osnat Rosen, Arieh Schwartz   +2 more
exaly  

Botulinum antitoxin/epinephrine

Reactions Weekly, 2019
openaire   +1 more source

Safety and Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for Confirmed or Suspected Botulism in the United States

Clinical Infectious Diseases, 2020
, Geraldine Parrera, Deborah M Anderson
exaly  

Antitoxin responses to Clostridium botulinum vaccines types C and D in guinea pigs.

Developments in biological standardization, 1977
In guinea pigs, the type C and/or type D antitoxin responses to a single dose of a bivalent or monovalent Cl. botulinum vaccine increase markedly between the fourth and ninth week after injection and still increase markedly by the ninth week. For type C, a similar pattern has been found in cattle.
openaire   +1 more source

Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin

Toxicon, 2013
Yasushi Torii, Tomoko Kohda, Motohide Takahashi   +2 more
exaly  

Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup—Allergic Reactions to Botulinum Antitoxin: A Systematic Review

Clinical Infectious Diseases, 2018
Leslie Grammer, Anna Nowak-Wegrzyn, Edith Schüssler   +2 more
exaly  

Development of in vitro functional replacement assays for Botulinum toxin and antitoxin preparations

2011
Botulinum neurotoxins are lethal toxins that induce prolonged muscle paralysis by blocking the release of neuronal transmitters from peripheral cholinergic nerve endings. Although highly toxic, botulinum toxins are available as licensed drugs for the treatment of a variety of medical disorders and increasingly applied for cosmetic purposes which ...
openaire   +1 more source